Cargando…
Impact of administration route on nanocarrier biodistribution in a murine colitis model
The incidence of inflammatory bowel disease (IBD) is increasing worldwide. Although current diagnostic and disease monitoring tests for IBD sensitively detect gut inflammation, they lack the molecular and cellular specificity of positron emission tomography (PET). In this proof-of-concept study, we...
Autores principales: | Applegate, Catherine C., Deng, Hongping, Kleszynski, Brittany L., Cross, Tzu-Wen L., Konopka, Christian J., Dobrucki, L. Wawrzyniec, Nelson, Erik R., Wallig, Matthew A., Smith, Andrew M., Swanson, Kelly S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038121/ https://www.ncbi.nlm.nih.gov/pubmed/36968097 http://dx.doi.org/10.1080/17458080.2022.2134563 |
Ejemplares similares
-
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
por: Wiklander, Oscar P. B., et al.
Publicado: (2015) -
Fluorophore Localization Determines the Results of Biodistribution of Core-Shell Nanocarriers
por: Hinz, Alicja, et al.
Publicado: (2022) -
Nanomaterials-Based siRNA Delivery: Routes of Administration, Hurdles and Role of Nanocarriers
por: Gupta, Nitin, et al.
Publicado: (2019) -
Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung
por: Wang, Lu, et al.
Publicado: (2021) -
Dendrimer-decorated nanogels: Efficient nanocarriers for biodistribution in vivo and chemotherapy of ovarian carcinoma
por: Li, Xin, et al.
Publicado: (2021)